{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "inverse": false,
    "derivatives": true,
    "swaps": true,
    "complex_factors": [
        "3x daily leverage",
        "Synthetic replication via unfunded swaps",
        "Complex index tracking (MSFXSM Triple Long US Dollar/GBP Total Return Index)",
        "Daily compounding effect",
        "Counterparty risk from swap agreements"
    ],
    "classification": "complex",
    "supporting_data": "The product is classified as complex under MiFID II due to several key factors: 1) It uses 3x daily leverage, which significantly amplifies risk and requires sophisticated understanding; 2) It employs synthetic replication through unfunded swaps, introducing counterparty risk; 3) The index tracked is a complex leveraged FX index with daily compounding effects; 4) The product is explicitly stated to be 'not simple and may be difficult to understand' in the KIID; 5) The risk rating is 7/7, the highest level; 6) The product is not UCITS compliant, which often correlates with complexity; 7) The recommended holding period is 1 day, indicating high volatility and complexity. While the product is fully collateralized, the combination of these factors makes it unsuitable for retail investors without specialized knowledge.",
    "confidence": 95,
    "counter_argument": "One might argue that the product is fully collateralized and trades on exchange, which could suggest lower complexity. However, the daily leverage, synthetic structure, and high-risk profile override this consideration under MiFID II guidelines.",
    "risk_level_assessment": "The product's risk profile is extremely high (7/7), with the potential for significant losses due to leverage and volatility. The complexity of the underlying index and derivative structure further compounds the risk, making it unsuitable for retail investors without specialized knowledge."
}